Literature DB >> 25701092

The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.

Einat Avital Schmutz1, Michael Bruce Zimmermann1, Sabine Rohrmann2.   

Abstract

BACKGROUND: Low serum 25-hydroxyvitamin D [25(OH)D] levels have been associated with higher risk of many diseases that affect mortality, including cardiovascular disease (CVD) and cancer. The inverse association between serum 25(OH)D and mortality may be modified by excess circulating vitamin A, due to interactions of vitamin A at the level of the vitamin D nuclear receptor. In this prospective cohort study, we investigated whether the association of 25(OH)D with all-cause, cancer, and CVD mortality was modified by circulating vitamin A or preformed vitamin A intake from supplements.
METHODS: We analyzed 15,998 adults in the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Mortality data for all-cause (n = 3890), cancer (n = 844), and CVD mortality (n = 1715) were assessed through December 2006. Serum 25(OH)D was measured using a radioimmunoassay kit, vitamin A biomarkers were measured by HPLC, and information on supplement use was obtained by self-report. Multivariable hazard ratios (HRs) and corresponding 95% confidence intervals (CI) were estimated by proportional hazards regression.
RESULTS: Serum 25(OH)D was significantly inversely associated with all-cause mortality (HR 0.93, 95% CI 0.89, 0.97, per 10 ng/mL increase) and also with CVD mortality and mortality due to non-cancer/non-cardiovascular causes, but not with cancer mortality. The observed inverse associations remained statistically significant only among participants with serum retinyl esters <7.0 μg/dL. High intake (>5000 IU/day) of preformed vitamin A from supplements attenuated the inverse association of 25(OH)D with overall mortality. The observed interactions were not statistically significant.
CONCLUSIONS: 25(OH)D was inversely associated with overall mortality, CVD mortality, and mortality due to non-cancer/non-CVD causes, but not with cancer mortality. A possible interaction between vitamin A exposure and 25(OH)D concentration appears to be associated with an attenuation of the inverse association between risk of death and quartile of 25(OH)D concentration.

Entities:  

Keywords:  Mortality; NHANES III; Vitamin A; Vitamin D

Mesh:

Substances:

Year:  2015        PMID: 25701092     DOI: 10.1007/s00394-015-0860-y

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  55 in total

1.  Dietary supplement use in the United States, 2003-2006.

Authors:  Regan L Bailey; Jaime J Gahche; Cindy V Lentino; Johanna T Dwyer; Jody S Engel; Paul R Thomas; Joseph M Betz; Christopher T Sempos; Mary Frances Picciano
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 3.  Epidemiology of vitamin D insufficiency and cancer mortality.

Authors:  Stefan Pilz; Andreas Tomaschitz; Barbara Obermayer-Pietsch; Harald Dobnig; Thomas R Pieber
Journal:  Anticancer Res       Date:  2009-09       Impact factor: 2.480

Review 4.  Vitamin D and cancer: the promise not yet fulfilled.

Authors:  Daniel D Bikle
Journal:  Endocrine       Date:  2014-01-09       Impact factor: 3.633

Review 5.  The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Authors:  M R Haussler; C A Haussler; P W Jurutka; P D Thompson; J C Hsieh; L S Remus; S H Selznick; G K Whitfield
Journal:  J Endocrinol       Date:  1997-09       Impact factor: 4.286

Review 6.  Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.

Authors:  Lu Wang; Yiqing Song; Joann E Manson; Stefan Pilz; Winfried März; Karl Michaëlsson; Annamari Lundqvist; Simerjot K Jassal; Elizabeth Barrett-Connor; Cuilin Zhang; Charles B Eaton; Heidi T May; Jeffrey L Anderson; Howard D Sesso
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11-13

7.  Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies.

Authors:  Armin Zittermann; Simona Iodice; Stefan Pilz; William B Grant; Vincenzo Bagnardi; Sara Gandini
Journal:  Am J Clin Nutr       Date:  2011-12-14       Impact factor: 7.045

8.  Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.

Authors:  Y Bao; K Ng; B M Wolpin; D S Michaud; E Giovannucci; C S Fuchs
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

9.  1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion.

Authors:  S Lee; S A Clark; R K Gill; S Christakos
Journal:  Endocrinology       Date:  1994-04       Impact factor: 4.736

10.  A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over.

Authors:  C J Bates; M Hamer; G D Mishra
Journal:  Osteoporos Int       Date:  2011-03-05       Impact factor: 4.507

View more
  3 in total

Review 1.  The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease.

Authors:  Jiawei Li; Paul Cordero; Vi Nguyen; Jude A Oben
Journal:  Integr Med Insights       Date:  2016-04-27

2.  Vitamin D Status and Mortality: A Systematic Review of Observational Studies.

Authors:  Alicia K Heath; Iris Y Kim; Allison M Hodge; Dallas R English; David C Muller
Journal:  Int J Environ Res Public Health       Date:  2019-01-29       Impact factor: 3.390

3.  Basal Vitamin D Status and Supplement Dose Are Primary Contributors to Maternal 25-Hydroxyvitamin D Response to Prenatal and Postpartum Cholecalciferol Supplementation.

Authors:  Benjamin Levy; Karen M O'Callaghan; Huma Qamar; Abdullah Al Mahmud; Alison D Gernand; M Munirul Islam; Daniel E Roth
Journal:  J Nutr       Date:  2021-11-02       Impact factor: 4.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.